Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: Early outcomes following the use of sirolimus-eluting stents

Journal of Cardiovascular Surgery

Volumn 47, Issue 2, 2006, Pages 171-176

  Bosiers, Marc ^a,b   Deloose, K ^a,b   Verbist, J ^a,b   Peeters, P ^a,b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Ischaemia; Limb; Peripheral angiopathies; Sirolimus; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; NADROPARIN; RAPAMYCIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; LIMB ISCHEMIA; LIMB SALVAGE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE THROMBOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SEPTICEMIA; SURVIVAL RATE; TREATMENT OUTCOME; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33646257557     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. TransAtlantic Inter-Society Consensus (TASC) on Management of Peripheral Arterial Disease (PAD) J Vasc Surg 2000; 31:1-296.
2. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94:3026-69.
3. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989; 3: 273-7.
4. The European Working Group on Critical Leg Ischemia. Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation 1991;84 (suppl IV):IV-1-IV-26.
5. Mousa A, Rhee JY, Trocciola SM, Dayal R, Beauford RB, Kumar N et al. Percutaneous endovascular treatment for chronic limb ischemia. Ann Vasc Surg 2005;19:186-91.
6. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
7. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
8. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
9. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-5.
10. Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005;294:819-25.
11. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-70.
12. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-62.
13. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;112:2175-83.
14. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-9.
15. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial. J Vasc Interv Radiol 2005;16:331-8.
16. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five year follow-up. Circulation 2001;104:2057-62.
17. Hanna GP, Fujise K, Kjellgren O, Feld S, Fife C, Schroth G et al. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol 1997;30:664-9.
18. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998;28:1066-71.
19. Dorros G, Jaff MR, Murphy KJ, Mathiak L. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn 1998;45:251-6.
20. Bolia A. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg (Torino) 2005;46:385-94.
21. Tsetis D, Belli AM. The role of infrapopliteal angioplasty. Br J Radiol 2004;77:1007-15.
22. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one year outcomes. J Am Coll Cardiol 2004;44:2307-14.
23. Rand T, Basile A, Cejna M, Fleischmann D, Funovics M, Gschwendtner M et al. PTA Versus Carbofilm-Coated Stents in Infrapopliteal Arteries: Pilot Study. Cardiovasc Intervent Radiol 2006;29:29-38.
24. Bosiers M, Deloose K, Verbist J, Peeters P. First Clinical Application of Absorbable Metal Stents in the Treatment of Critical Limb Ischemia: 12-month results. Vascular Disease Management 2005;2:86-91.
25. Mauri L, Orav EJ, O'Malley AJ, Moses JW, Leon MB, Holmes DR Jr et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 2005;111:321-7.
26. Soder HK, Manninen HI, Jaakkola P, Matsi PJ, Rasanen HT, Kaukanen E et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000;11:1021-31.
27. Boyer L, Therre T, Garcier JM, Perez N, Ravel A, Privat C et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol 2000; 41:73-7.
28. Kandarpa K, Becker GJ, Hunink MG, McNamara TO, Rundback JH, Trost DW et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol 2001; 12: 683-95.